A review of obstructive sleep apnea and lung cancer: epidemiology, pathogenesis, and therapeutic options

Despite undeniable advances in modern medicine, lung cancer still has high morbidity and mortality rates. Lung cancer is preventable and treatable, and it is important to identify new risk factors for lung cancer, especially those that can be treated or reversed. Obstructive sleep apnea (OSA) is a v...

Full description

Bibliographic Details
Main Authors: Fang Yuan, Yanxia Hu, Fei Xu, Xujun Feng
Format: Article
Language:English
Published: Frontiers Media S.A. 2024-03-01
Series:Frontiers in Immunology
Subjects:
Online Access:https://www.frontiersin.org/articles/10.3389/fimmu.2024.1374236/full
_version_ 1797238439846871040
author Fang Yuan
Yanxia Hu
Fei Xu
Xujun Feng
Xujun Feng
author_facet Fang Yuan
Yanxia Hu
Fei Xu
Xujun Feng
Xujun Feng
author_sort Fang Yuan
collection DOAJ
description Despite undeniable advances in modern medicine, lung cancer still has high morbidity and mortality rates. Lung cancer is preventable and treatable, and it is important to identify new risk factors for lung cancer, especially those that can be treated or reversed. Obstructive sleep apnea (OSA) is a very common sleep-breathing disorder that is grossly underestimated in clinical practice. It can cause, exacerbate, and worsen adverse outcomes, including death and various diseases, but its relationship with lung cancer is unclear. A possible causal relationship between OSA and the onset and progression of lung cancer has been established biologically. The pathophysiological processes associated with OSA, such as sleep fragmentation, intermittent hypoxia, and increased sympathetic nervous excitation, may affect normal neuroendocrine regulation, impair immune function (especially innate and cellular immunity), and ultimately contribute to the occurrence of lung cancer, accelerate progression, and induce treatment resistance. OSA may be a contributor to but a preventable cause of the progression of lung cancer. However, whether this effect exists independently of other risk factors is unclear. Therefore, by reviewing the literature on the epidemiology, pathogenesis, and treatment of lung cancer and OSA, we hope to understand the relationships between the two and promote the interdisciplinary exchange of ideas between basic medicine, clinical medicine, respiratory medicine, sleep medicine, and oncology.
first_indexed 2024-04-24T17:35:40Z
format Article
id doaj.art-02bc666a13ea4b03bc96de4fbe15a5a9
institution Directory Open Access Journal
issn 1664-3224
language English
last_indexed 2024-04-24T17:35:40Z
publishDate 2024-03-01
publisher Frontiers Media S.A.
record_format Article
series Frontiers in Immunology
spelling doaj.art-02bc666a13ea4b03bc96de4fbe15a5a92024-03-28T04:41:31ZengFrontiers Media S.A.Frontiers in Immunology1664-32242024-03-011510.3389/fimmu.2024.13742361374236A review of obstructive sleep apnea and lung cancer: epidemiology, pathogenesis, and therapeutic optionsFang Yuan0Yanxia Hu1Fei Xu2Xujun Feng3Xujun Feng4Department of Respiratory, The First Hospital of Jiujiang City, Jiujiang, ChinaDepartment of Respiratory, The First Hospital of Jiujiang City, Jiujiang, ChinaDepartment of Respiratory and Critical Care Medicine, The First Affiliated Hospital, Jiangxi Medical College, Nanchang University, Nanchang, ChinaDepartment of Respiratory, The First Hospital of Jiujiang City, Jiujiang, ChinaDepartment of Respiratory and Critical Care Medicine, Sleep Medicine Center, Mental Health Center, West China Hospital, Sichuan University, Chengdu, ChinaDespite undeniable advances in modern medicine, lung cancer still has high morbidity and mortality rates. Lung cancer is preventable and treatable, and it is important to identify new risk factors for lung cancer, especially those that can be treated or reversed. Obstructive sleep apnea (OSA) is a very common sleep-breathing disorder that is grossly underestimated in clinical practice. It can cause, exacerbate, and worsen adverse outcomes, including death and various diseases, but its relationship with lung cancer is unclear. A possible causal relationship between OSA and the onset and progression of lung cancer has been established biologically. The pathophysiological processes associated with OSA, such as sleep fragmentation, intermittent hypoxia, and increased sympathetic nervous excitation, may affect normal neuroendocrine regulation, impair immune function (especially innate and cellular immunity), and ultimately contribute to the occurrence of lung cancer, accelerate progression, and induce treatment resistance. OSA may be a contributor to but a preventable cause of the progression of lung cancer. However, whether this effect exists independently of other risk factors is unclear. Therefore, by reviewing the literature on the epidemiology, pathogenesis, and treatment of lung cancer and OSA, we hope to understand the relationships between the two and promote the interdisciplinary exchange of ideas between basic medicine, clinical medicine, respiratory medicine, sleep medicine, and oncology.https://www.frontiersin.org/articles/10.3389/fimmu.2024.1374236/fullobstructive sleep apnealung cancerintermittent hypoxiaepidemiologytumor associated macrophages
spellingShingle Fang Yuan
Yanxia Hu
Fei Xu
Xujun Feng
Xujun Feng
A review of obstructive sleep apnea and lung cancer: epidemiology, pathogenesis, and therapeutic options
Frontiers in Immunology
obstructive sleep apnea
lung cancer
intermittent hypoxia
epidemiology
tumor associated macrophages
title A review of obstructive sleep apnea and lung cancer: epidemiology, pathogenesis, and therapeutic options
title_full A review of obstructive sleep apnea and lung cancer: epidemiology, pathogenesis, and therapeutic options
title_fullStr A review of obstructive sleep apnea and lung cancer: epidemiology, pathogenesis, and therapeutic options
title_full_unstemmed A review of obstructive sleep apnea and lung cancer: epidemiology, pathogenesis, and therapeutic options
title_short A review of obstructive sleep apnea and lung cancer: epidemiology, pathogenesis, and therapeutic options
title_sort review of obstructive sleep apnea and lung cancer epidemiology pathogenesis and therapeutic options
topic obstructive sleep apnea
lung cancer
intermittent hypoxia
epidemiology
tumor associated macrophages
url https://www.frontiersin.org/articles/10.3389/fimmu.2024.1374236/full
work_keys_str_mv AT fangyuan areviewofobstructivesleepapneaandlungcancerepidemiologypathogenesisandtherapeuticoptions
AT yanxiahu areviewofobstructivesleepapneaandlungcancerepidemiologypathogenesisandtherapeuticoptions
AT feixu areviewofobstructivesleepapneaandlungcancerepidemiologypathogenesisandtherapeuticoptions
AT xujunfeng areviewofobstructivesleepapneaandlungcancerepidemiologypathogenesisandtherapeuticoptions
AT xujunfeng areviewofobstructivesleepapneaandlungcancerepidemiologypathogenesisandtherapeuticoptions
AT fangyuan reviewofobstructivesleepapneaandlungcancerepidemiologypathogenesisandtherapeuticoptions
AT yanxiahu reviewofobstructivesleepapneaandlungcancerepidemiologypathogenesisandtherapeuticoptions
AT feixu reviewofobstructivesleepapneaandlungcancerepidemiologypathogenesisandtherapeuticoptions
AT xujunfeng reviewofobstructivesleepapneaandlungcancerepidemiologypathogenesisandtherapeuticoptions
AT xujunfeng reviewofobstructivesleepapneaandlungcancerepidemiologypathogenesisandtherapeuticoptions